A comparison of an interferon-gamma release assay and tuberculin skin test in refractory inflammatory disease patients screened for latent tuberculosis prior to the initiation of a first tumor necrosis factor α inhibitor

Clinical Rheumatology

Volumn 30, Issue 4, 2011, Pages 505-510

  Kwakernaak, Arjan J ^a   Houtman, Pieternella M ^a   Weel, Jan F L ^b   Spoorenberg, Johanna P L ^a   Jansen, Tim L T A ^a  

^a MEDICAL CENTER LEEUWARDEN   (Netherlands)

^b Public Health Service of Northern Friesland   (Netherlands)

Author keywords

CD4+ T lymphocyte cell count; IGRA; Immune mediated inflammatory disease; Latent tuberculosis infection; TNF inhibition; TST

Indexed keywords

AZATHIOPRINE; BCG VACCINE; CORTICOSTEROID DERIVATIVE; GAMMA INTERFERON; LEFLUNOMIDE; METHOTREXATE; METHYLPREDNISOLONE; TUMOR NECROSIS FACTOR ALPHA INHIBITOR;

ADULT; ADULT ONSET STILL DISEASE; ANKYLOSING SPONDYLITIS; ARTICLE; ASSAY; CD4 LYMPHOCYTE COUNT; CELLULAR IMMUNITY; COMPARATIVE STUDY; DIAGNOSTIC TEST ACCURACY STUDY; DIAGNOSTIC VALUE; DRUG MEGADOSE; FALSE POSITIVE RESULT; FEMALE; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; INFECTION PREVENTION; INFLAMMATORY DISEASE; JUVENILE RHEUMATOID ARTHRITIS; LATENT TUBERCULOSIS; MAJOR CLINICAL STUDY; MALE; MEDICAL HISTORY; PRIORITY JOURNAL; PROTEIN SECRETION; PSORIATIC ARTHRITIS; RHEUMATOID ARTHRITIS; SARCOIDOSIS; SPONDYLOARTHROPATHY; TUBERCULIN TEST; TUBERCULOSIS;

ARTHRITIS, RHEUMATOID; AZATHIOPRINE; BIOLOGICAL ASSAY; CD4-POSITIVE T-LYMPHOCYTES; FEMALE; GLUCOCORTICOIDS; HUMANS; IMMUNITY, CELLULAR; INTERFERON-GAMMA; ISOXAZOLES; LATENT TUBERCULOSIS; MALE; METHOTREXATE; MIDDLE AGED; PROSPECTIVE STUDIES; TUBERCULIN TEST; TUMOR NECROSIS FACTOR-ALPHA;

EID: 79954431150     PISSN: 07703198     EISSN: None     Source Type: Journal    
DOI: 10.1007/s10067-010-1550-z     Document Type: Article

References (35)

1. JS Smolen D Aletaha M Koeller MH Weisman P Emery 2007 New therapies for treatment of rheumatoid arthritis Lancet 370 1861 1874 17570481 10.1016/S0140-6736(07)60784-3 1:CAS:528:DC%2BD2sXhsVSgs7vF (Pubitemid 350180008)
2. PJ Mease 2009 Psoriatic arthritis assessment and treatment update Curr Opin Rheumatol 21 348 355 19461518 10.1097/BOR.0b013e32832c7832
3. J Braun J Davis M Dougados J Sieper S van der Linden D van der Heijde 2006 First update of the international ASAS consensus statement for the use of anti-TNF agents in patients with ankylosing spondylitis Ann Rheum Dis 65 316 320 16096329 10.1136/ard.2005.040758 1:CAS:528:DC%2BD28XisFCjt7k%3D (Pubitemid 43268219)
4. P Quartier P Taupin F Bourdeaut, et al. 2003 Efficacy of etanercept for the treatment of juvenile idiopathic arthritis according to the onset type Arthritis Rheum 48 1093 1101 12687553 10.1002/art.10885 1:CAS:528: DC%2BD3sXjtlKns7g%3D (Pubitemid 36418252)
5. HG Kraetsch C Antoni JR Kalden B Manger 2001 Successful treatment of a small cohort of patients with adult onset of Still's disease with infliximab: first experiences Ann Rheum Dis 60 Suppl 3 iii55 iii57 11890655 1:CAS:528:DC%2BD3MXotlGiu70%3D
6. S Saleh S Ghodsian V Yakimova J Henderson OP Sharma 2006 Effectiveness of infliximab in treating selected patients with sarcoidosis Respir Med 100 2053 2059 16935484 10.1016/j.rmed.2006.02.017 (Pubitemid 44514944)
7. T Bongartz AJ Sutton MJ Sweeting I Buchan EL Matteson V Montori 2006 Anti-TNF antibody therapy in rheumatoid arthritis and the risk of serious infections and malignancies: systematic review and meta-analysis of rare harmful effects in randomized controlled trials JAMA 295 2275 2285 16705109 10.1001/jama.295.19.2275 1:CAS:528:DC%2BD28Xksl2ktrk%3D (Pubitemid 43736578)
8. NM Patkar GG Teng JR Curtis KG Saag 2008 Association of infections and tuberculosis with antitumor necrosis factor alpha therapy Curr Opin Rheumatol 20 320 326 18388525 10.1097/BOR.0b013e3282fa74f7 1:CAS:528:DC%2BD1cXkt1SlsLw%3D (Pubitemid 351483323)
9. J Keane S Gershon RP Wise, et al. 2001 Tuberculosis associated with infliximab, a tumor necrosis factor alpha-neutralizing agent N Engl J Med 345 1098 1104 11596589 10.1056/NEJMoa011110 1:CAS:528:DC%2BD3MXnsFShsr0%3D
10. JJ Gomez-Reino L Carmona M Angel Descalzo 2007 Risk of tuberculosis in patients treated with tumor necrosis factor antagonists due to incomplete prevention of reactivation of latent infection Arthritis Rheum 57 756 761 17530674 10.1002/art.22768 1:CAS:528:DC%2BD2sXnsFyiu7w%3D (Pubitemid 46932080)
11. P Andersen ME Munk JM Pollock TM Doherty 2000 Specific immune-based diagnosis of tuberculosis Lancet 356 1099 1104 11009160 10.1016/S0140-6736(00) 02742-2 1:CAS:528:DC%2BD3cXnsVCktbw%3D
12. Diagnostic Standards and Classification of Tuberculosis in Adults and Children. This official statement of the American Thoracic Society and the Centers for Disease Control and Prevention was adopted by the ATS Board of Directors, July 1999. This statement was endorsed by the Council of the Infectious Disease Society of America, September 1999. Am J Respir Crit Care Med 2000; 161:1376-1395
13. DY Chen GH Shen TY Hsieh CW Hsieh JL Lan 2008 Effectiveness of the combination of a whole-blood interferon-gamma assay and the tuberculin skin test in detecting latent tuberculosis infection in rheumatoid arthritis patients receiving adalimumab therapy Arthritis Rheum 59 800 806 18512714 10.1002/art.23705 1:CAS:528:DC%2BD1cXot1Wgs7k%3D (Pubitemid 351847562)
14. J Pouchot A Grasland C Collet J Coste JM Esdaile P Vinceneux 1997 Reliability of tuberculin skin test measurement Ann Intern Med 126 210 214 9027271 1:STN:280:DyaK2s7lvV2gsg%3D%3D (Pubitemid 27061574)
15. I Brock K Weldingh T Lillebaek F Follmann P Andersen 2004 Comparison of tuberculin skin test and new specific blood test in tuberculosis contacts Am J Respir Crit Care Med 170 65 69 15087297 10.1164/rccm.200402-232OC (Pubitemid 38997753)
16. YA Kang HW Lee HI Yoon, et al. 2005 Discrepancy between the tuberculin skin test and the whole-blood interferon gamma assay for the diagnosis of latent tuberculosis infection in an intermediate tuberculosis-burden country JAMA 293 2756 2761 15941805 10.1001/jama.293.22.2756 1:CAS:528:DC%2BD2MXltVCgurY%3D (Pubitemid 40965087)
17. M Pai LW Riley JM Colford Jr 2004 Interferon-gamma assays in the immunodiagnosis of tuberculosis: a systematic review Lancet Infect Dis 4 761 776 15567126 10.1016/S1473-3099(04)01206-X 1:CAS:528:DC%2BD2MXisV2lug%3D%3D (Pubitemid 39574348)
18. A Lalvani 2007 Diagnosing tuberculosis infection in the 21st century: new tools to tackle an old enemy Chest 131 6 1898 1906 17565023 10.1378/chest.06-2471 (Pubitemid 46981652)
19. Dutch Society of Rheumatology (2003) Tuberculosis and TNFa-blockade (guideline)
20. GH Mazurek ME Villarino 2003 Guidelines for using the QuantiFERON-TB test for diagnosing latent mycobacterium tuberculosis infection. Centers for disease control and prevention MMWR Recomm Rep 31 15 18
21. EM Leyten SM Arend C Prins FG Cobelens TH Ottenhoff JT van Dissel 2007 Discrepancy between mycobacterium tuberculosis-specific gamma interferon release assays using short and prolonged in vitro incubation Clin Vaccine Immunol 14 880 885 17507543 10.1128/CVI.00132-07 1:CAS:528:DC%2BD2sXotlGmu7g%3D
22. S O'Neal K Hedberg A Markum S Schafer 2009 Discordant tuberculin skin and interferon-gamma tests during contact investigations: a dilemma for tuberculosis controllers Int J Tuberc Lung Dis 13 5 662 664 19383203
23. A Saracino G Scotto C Fornabaio, et al. 2009 Quantiferon-TB Gold in-tube test (QFT-GIT) for the screening of latent tuberculosis in recent immigrants in Italy New Microbiol 32 369 376 20128443
24. Y Kobashi Y Obase M Fukuda N Miyashita M Oka 2007 Clinical evaluation of QuantiFERON TB-2G test for immunocompromised patients Eur Respir J 30 945 950 17652312 10.1183/09031936.00040007 1:CAS:528:DC%2BD2sXhsVans7%2FL (Pubitemid 351194799)
25. L Richeldi M Losi R D'Amico, et al. 2010 Performance of tests for latent tuberculosis in different groups of immunocompromised patients Chest 136 198 204 10.1378/chest.08-2575
26. JD Greenberg SM Reddy SG Schloss, et al. 2008 Comparison of an in vitro tuberculosis interferon-gamma assay with delayed-type hypersensitivity testing for detection of latent mycobacterium tuberculosis: a pilot study in rheumatoid arthritis J Rheumatol 35 770 775 18322990 (Pubitemid 351747115)
27. G Matulis P Juni PM Villiger SD Gadola 2008 Detection of latent tuberculosis in immunosuppressed patients with autoimmune diseases: performance of a mycobacterium tuberculosis antigen-specific interferon gamma assay Ann Rheum Dis 67 84 90 17644549 10.1136/ard.2007.070789 1:CAS:528: DC%2BD1cXhs1ejtLk%3D
28. B Soborg M Ruhwald ML Hetland, et al. 2009 Comparison of screening procedures for mycobacterium tuberculosis infection among patients with inflammatory diseases J Rheumatol 36 1876 1884 19648300 10.3899/jrheum.081292 27
29. N Inanc SZ Aydin S Karakurt P Atagunduz S Yavuz H Direskeneli 2009 Agreement between Quantiferon-TB Gold test and tuberculin skin test in the identification of latent tuberculosis infection in patients with rheumatoid arthritis and ankylosing spondylitis J Rheumatol 36 2675 2681 19918035 10.3899/jrheum.090268
30. F Bartalesi S Vicidomini D Goletti, et al. 2009 Quantiferon-TB Gold and the TST are both useful for latent tuberculosis infection screening in autoimmune diseases Eur Respir J 33 586 593 19047313 10.1183/09031936.00107608 1:STN:280:DC%2BD1M7nt1Cguw%3D%3D
31. EY Kim JY Jung JY Son, et al. 2009 Performance of the tuberculin skin test and interferon-gamma release assay for detection of tuberculosis infection in immunocompromised patients in a BCG-vaccinated population BMC Infect Dis 15 9 207
32. J Martin C Walsh A Gibbs, et al. 2010 Comparison of interferon-{gamma}- release assays and conventional screening tests before tumour necrosis factor-{alpha} blockade in patients with inflammatory arthritis Ann Rheum Dis 69 181 185 19176545 10.1136/ard.2008.101857 1:CAS:528:DC%2BC3cXhtFOls7Y%3D
33. British National Institute for Health and Clinical Excellence (2006). Tuberculosis; clinical diagnosis and management of tuberculosis and measures for its prevention and control (guideline). London, UK:NICE:2006. http://www.nice.org.uk/guidance/CG33. Accessed March 2009
34. C Beglinger J Dudler C Mottet, et al. 2007 Screening for tuberculosis infection before the initiation of an anti-TNF-alpha therapy Swiss Med Wkly 137 620 622 17990157
35. R Diel B Hauer R Loddenkemper B Manger K Kruger 2009 Recommendations for tuberculosis screening before initiation of TNF-alpha-inhibitor treatment in rheumatic diseases Pneumologie 63 329 334 19517358 10.1055/s-0029-1214673 1:STN:280:DC%2BD1Mvht1Wgsw%3D%3D